Show simple item record

dc.contributor.authorHenman, Martin
dc.contributor.authorALMUTAIRI, HADIAH KHALAF
dc.contributor.authorO'Dwyer, Maire
dc.contributor.authorMc Carron, Mary
dc.contributor.authorMcCallion, Philip
dc.date.accessioned2020-01-22T17:01:10Z
dc.date.available2020-01-22T17:01:10Z
dc.date.issued2018
dc.date.submitted2018en
dc.identifier.citationAlmutari, H., O'Dwyer, M., McCarron, M., McCallion, P., & Henman, M., The Use of Proton Pump Inhibitors Among Older Adults with Intellectual Disability: A Cross Sectional Observational Study., Saudi Pharmaceutical Journal, 26, 7, 2018, 1012 - 1021en
dc.identifier.issn2213-7475 1319-0164
dc.identifier.otherY
dc.description.abstractBackground: Older people with Intellectual Disability (ID) have a high prevalence of gastrointestinal conditions such as Gastro-Oesophageal Reflux Disease (GORD). However, despite this, information about treatment, in particular the use of Proton Pump Inhibitors (PPIs), in this population is sparse and limited. Objective: To investigate the prevalence and pattern of PPI use among older people with ID. Method: Data on PPI use and key demographics was analysed from Wave 2 (2013/2014) of IDS-TILDA, a nationally representative longitudinal study of 677 participants aged 40 years and above in Ireland. Descriptive statistics, bivariate analyses and binary logistic regression were carried out. Results: Just over a quarter, 27.9% (n = 189), of participants reported use of PPIs, and 53.4% (n = 101) were female. The largest proportion of PPI users (53.4%) were aged between 50 and 64 yrs. Most of the PPIs were used in maximum doses (66.7%). However only 43.9% of PPI users had an indication for PPI use (GORD, stomach ulcer or/and an NSAID use), and further 13.2% were also taking an antiplatelet agent. Use among those in residential care homes (54.3%) was much higher than for those living independently or with family (7%). PPI use among those who have severe/profound ID was 25% higher than those with mild ID. Information about the length of PPI use was missing for 31.2%, but of those with data, just over half recorded using the PPIs for more than a year. Apart from an indication, the factors associated with PPI use were older ages (over 50 years), severe/profound level of ID. Conclusion: PPI use among older people with intellectual disability is prevalent and frequently long term, often without a clear indication. PPI use especially among those with severe/profound ID and those who live in residential care homes, could predispose these individuals to additional comorbidities and in order to avoid inappropriate long term of use regular review is required.en
dc.description.sponsorshipHealth Research Board (HRB) and the Department of Health. Saudi Ministry of Education, King Abdullah Scholarship.en
dc.format.extent1012en
dc.format.extent1021en
dc.language.isoenen
dc.relation.ispartofseriesSaudi Pharmaceutical Journal;
dc.relation.ispartofseries26;
dc.relation.ispartofseries7;
dc.rightsYen
dc.subjectOlder peopleen
dc.subjectIntellectual disabilityen
dc.subjectProton pump inhibitorsen
dc.subjectMedicine useen
dc.subjectInappropriateen
dc.subjectPolypharmacyen
dc.subjectMedicationen
dc.subjectPeptic ulcer diseaseen
dc.titleThe Use of Proton Pump Inhibitors Among Older Adults with Intellectual Disability: A Cross Sectional Observational Study.en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/mhenman
dc.identifier.peoplefinderurlhttp://people.tcd.ie/modwyer6
dc.identifier.peoplefinderurlhttp://people.tcd.ie/mccarrm
dc.identifier.peoplefinderurlhttp://people.tcd.ie/almutaih
dc.identifier.rssinternalid190287
dc.identifier.doihttps://doi.org/10.1016/j.jsps.2018.05.009
dc.rights.ecaccessrightsopenAccess
dc.relation.doihttps://doi.org/10.1016/j.jsps.2018.05.009en
dc.relation.citesCitesen
dc.subject.TCDThemeAgeingen
dc.subject.TCDTagACID REFLUXen
dc.subject.TCDTagANTIULCER AGENTen
dc.subject.TCDTagAgeing & Intellectual Disability - Changing Service Needsen
dc.subject.TCDTagAgeing & Intellectual Disability Issuesen
dc.subject.TCDTagAgeing, Health and Intellectual Disabilityen
dc.subject.TCDTagAging and Intellectual Disabilityen
dc.subject.TCDTagClinical Pharmacyen
dc.subject.TCDTagGASTRIC ULCERen
dc.subject.TCDTagGASTRO-OESOPHAGEAL REFLUXen
dc.subject.TCDTagGASTRO-OESOPHAGEAL REFLUX DISEASEen
dc.subject.TCDTagGastroenterologyen
dc.subject.TCDTagINTELLECTUAL DISABILITIESen
dc.subject.TCDTagIntellectual Disabilityen
dc.subject.TCDTagNONULCER DYSPEPSIAen
dc.subject.TCDTagOlder people with intellectual disabilitiesen
dc.subject.TCDTagPEPTIC ULCERen
dc.subject.TCDTagPEPTIC-ULCER DISEASEen
dc.subject.TCDTagPHARMACOEPIDEMIOLOGYen
dc.subject.TCDTagPHARMACY PRACTICEen
dc.subject.TCDTagPOLYPHARMACYen
dc.subject.TCDTagPRESCRIBINGen
dc.subject.TCDTagPRESCRIBING PATTERNSen
dc.subject.TCDTagPROTON PUMP INHIBITORen
dc.subject.TCDTagPatient safetyen
dc.subject.TCDTagPractice of pharmacyen
dc.subject.TCDTagQUALITY PRESCRIBINGen
dc.subject.TCDTagRATIONAL PRESCRIBINGen
dc.subject.TCDTagREFLUX ESOPHAGITISen
dc.subject.TCDTagSYMPTOMATIC GASTROESOPHAGEAL REFLUXen
dc.identifier.orcid_id0000-0002-7922-7691
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1319016418301105?via%3Dihub
dc.identifier.urihttp://hdl.handle.net/2262/91362


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record